- THÉA GRUP
- GÖZ SAĞLIĞI
- ARAŞTIRMA VE İNOVASYON
- GLOBAL AKTİVİTELER
- THÉA VAKFI
- YAN ETKİ BİLDİRİMİ
- CANLI YAYIN
Research & Innovation
Innovations by Théa
In fewer than twenty years, under the leadership of Henri CHIBRET, Laboratoires Théa has achieved renown by greatly increasing innovations in all the therapeutic classes
1995 > Broad spectrum anti-allergic for treatment of allergy and associated inflammation. Preservative-free.
1996 > The 1st anti-herpetic gel.
1999 > The 1st fluid gel for dry eye treatment.
2002 > Food supplement in eye nutrition.
2005 > The 1st non-preserved hyaluronic acid in multi-dose bottle.
2007 > Preservative-free diclofenac eye drops.
2008 > The 1st low-dosed timolol gel with no quantifiable systemic adsorption.
2009 > The first 3-day ocular antibiotic.
2010 > Moist heat therapy for the management of MGD.
2011 > The 1st preservative-free multi-action anti-allergic in a bottle.
2012 > The 1st intracameral antibiotic for prophylaxis of endophthalmitis in cataract surgery.
2013 > 1st prostaglandin without preservatives in single dose format used for the treatment of glaucoma.
2013 > 1st association between trehalose and hyaluronic acid without preservatives in an ABAK® bottle for mild to severe dry eye.
2013 > Sterile and preservative-free gel for eyelid hygiene
2014 > 1st treatment of corneal scarring using ReGeneraTing Agents (RGTA®).
2015 > 1st fixed association of beta-blockers and carbonic anhydrase inhibitors in a bottle with Easygrip® technology, without preservatives, used for the treatment of glaucoma.
2016 > 1st intracameral solution for injection to obtain pupil dilation and intraocular anaesthesia directly in the operating room during cataract surgery.